Cargando…
Interleukin-10 inhibits osteoclastogenesis by reducing NFATc1 expression and preventing its translocation to the nucleus
BACKGROUND: IL-10 has a potent inhibitory effect on osteoclastogenesis. In vitro and in vivo studies confirm the importance of this cytokine in bone metabolism, for instance IL-10-deficient mice develop the hallmarks of osteoporosis. Although it is known that IL-10 directly inhibits osteoclastogenes...
Autores principales: | Evans, Kathryn E, Fox, Simon W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781937/ https://www.ncbi.nlm.nih.gov/pubmed/17239241 http://dx.doi.org/10.1186/1471-2121-8-4 |
Ejemplares similares
-
Transforming growth factor-β enables NFATc1 expression during osteoclastogenesis
por: Fox, S.W., et al.
Publicado: (2008) -
The Role of Ca(2+)-NFATc1 Signaling and Its Modulation on Osteoclastogenesis
por: Kang, Jung Yun, et al.
Publicado: (2020) -
Dectin-1 signaling inhibits osteoclastogenesis via IL-33-induced inhibition of NFATc1
por: Zhu, Xiaoqing, et al.
Publicado: (2017) -
Dracorhodin perchlorate inhibits osteoclastogenesis through repressing RANKL‐stimulated NFATc1 activity
por: Liu, Yuhao, et al.
Publicado: (2020) -
Adseverin mediates RANKL-induced osteoclastogenesis by regulating NFATc1
por: Song, Min-Kyoung, et al.
Publicado: (2015)